PT - JOURNAL ARTICLE AU - Ahmed, Faruque AU - Qualls, Noreen AU - Kowalczyk, Shelly AU - Cunningham, Suzanne Randolph AU - Zviedrite, Nicole AU - Uzicanin, Amra TI - Feasibility, Acceptability, and Barriers to Implementing Select Non-Pharmaceutical Interventions to Reduce the Transmission of Pandemic Influenza - United States, 2019 AID - 10.1101/2021.09.22.21263963 DP - 2021 Jan 01 TA - medRxiv PG - 2021.09.22.21263963 4099 - http://medrxiv.org/content/early/2021/09/23/2021.09.22.21263963.short 4100 - http://medrxiv.org/content/early/2021/09/23/2021.09.22.21263963.full AB - Objective To assess feasibility and acceptability of implementing non-pharmaceutical interventions (NPIs) reserved for influenza pandemics (voluntary home quarantine; use of face masks by ill persons; childcare facility closures; school closures; and social distancing at schools, workplaces, and mass gatherings), and the availability and usefulness of influenza surveillance data for triggering implementation of NPIs.Methods Public health officials in all 50 states, Washington, DC, and 8 territories, and a stratified, random sample of 822 local health departments (LHDs) were surveyed in 2019.Results The response rates for the states/territories and LHDs were 75% (44/59) and 25% (206/822), respectively. About two-thirds to three-fourths of the state/territorial respondents stated that the feasibility and acceptability of implementing the NPIs were high, except for K-12 school closures lasting up to 6 weeks or 6 months. The LHD respondents also indicated that feasibility and acceptability were lowest for prolonged school closures. Compared to LHD respondents in suburban or urban areas, those in rural areas expressed lower feasibility and acceptability. Availability of influenza surveillance data in near real-time was lowest for influenza-like illness and influenza cases in schools.Conclusions The findings can provide insights regarding the implementation of NPIs during the Corona Virus Disease 2019 (COVID-19) pandemic.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis is not a clinical trialFunding StatementCenters for Disease Control and PreventionAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Human Subjects Advisor, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, made the following determination: "Project does not meet the definition of research under 45 CFR 46.102(d). IRB review is not required." As the purpose of the project is to conduct a feasibility evaluation of a programmatic activity, it is consistent with non-research public health program evaluation, per CDC guidelines. The project is not designed to contribute to generalizable knowledge.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData can be shared upon request.